Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
merck
4
×
clinical trials
life sciences
national
national blog main
national top stories
new york blog main
abbvie
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
drugs
eli lilly
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
acne
agenus
allergan
amgen
astrazeneca
What
approved
fda
4
×
drug
new
treatment
adults
allergan
approval
bio
cancer
class
companies
deeper
digital
disease
dna
ebola
epidemic
ervebo
fatty
fingerprint
frenzied
genetic
going
growing
issues
known
led
liver
matter
medicine
medicines
merck
migraine
monday
nash
nd
news
nod
oks
Language
unset
Current search:
merck
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@engadget.com
4 years ago
FDA issues its first approval for an Ebola vaccine
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues